@article{SeethalerHertleinWeckleinetal.2019,
  author    = {Seethaler, Marius and Hertlein, Tobias and Wecklein, Bj{\"o}rn and Ymeraj, Alba and Ohlsen, Knut and Lalk, Michael and Hilgeroth, Andreas},
  title     = {Novel small-molecule antibacterials against Gram-positive pathogens of Staphylococcus and Enterococcus species},
  series = {Antibiotics},
  volume    = {8},
  journal   = {Antibiotics},
  number    = {4},
  issn      = {2079-6382},
  doi       = {10.3390/antibiotics8040210},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-193130},
  year      = {2019},
  abstract  = {Defeat of the antibiotic resistance of pathogenic bacteria is one great challenge today and for the future. In the last century many classes of effective antibacterials have been developed, so that upcoming resistances could be met with novel drugs of various compound classes. Meanwhile, there is a certain lack of research of the pharmaceutical companies, and thus there are missing developments of novel antibiotics. Gram-positive bacteria are the most important cause of clinical infections. The number of novel antibacterials in clinical trials is strongly restricted. There is an urgent need to find novel antibacterials. We used synthetic chemistry to build completely novel hybrid molecules of substituted indoles and benzothiophene. In a simple one-pot reaction, two novel types of thienocarbazoles were yielded. Both indole substituted compound classes have been evaluated as completely novel antibacterials against the Staphylococcus and Enterococcus species. The evaluated partly promising activities depend on the indole substituent type. First lead compounds have been evaluated within in vivo studies. They confirmed the in vitro results for the new classes of small-molecule antibacterials.},
  language  = {en}
}
@article{AshrafYasrebiHertleinetal.2017,
  author    = {Ashraf, Kerolos and Yasrebi, Kaveh and Hertlein, Tobias and Ohlsen, Knut and Lalk, Michael and Hilgeroth, Andreas},
  title     = {Novel effective small-molecule antibacterials against \(Enterococcus\) strains},
  series = {Molecules},
  volume    = {22},
  journal   = {Molecules},
  number    = {12},
  doi       = {10.3390/molecules22122193},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-172628},
  year      = {2017},
  abstract  = {\(Enterococcus\) species cause increasing numbers of infections in hospitals. They contribute to the increasing mortality rates, mostly in patients with comorbidities, who suffer from severe diseases. \(Enterococcus\) resistances against most antibiotics have been described, including novel antibiotics. Therefore, there is an ongoing demand for novel types of antibiotics that may overcome bacterial resistances. We discovered a novel class of antibiotics resulting from a simple one-pot reaction of indole and \(o\)-phthaldialdehyde. Differently substituted indolyl benzocarbazoles were yielded. Both the indole substitution and the positioning at the molecular scaffold influence the antibacterial activity towards the various strains of \(Enterococcus\) species with the highest relevance to nosocomial infections. Structure-activity relationships are discussed, and the first lead compounds were identified as also being effective in the case of a vancomycin resistance.},
  language  = {en}
}